FrancophonIA/ELRC3.0 huggingface dataset:
English: Concomitant therapy with other liposomal or lipid-complexed substances or intravenous fat emulsions could change the pharmacokinetic profile of Myocet liposomal.
Croatian: Istovremeno liječenje drugim liposomskim tvarima ili lipidnim kompleksima ili intravenskom emulzijom masti moglo bi promijeniti farmakokinetički profil lijeka
English: Abbreviations: PFS, progression-free survival; Dox, doxorubicin; Epi, epirubicin; Relative Risk, comparator taken as reference; Risk Ratio, Myocet liposomal taken as reference a
Croatian: Kratice: PFS, preživljenje bez napredovanja bolesti; Doks, doksorubicin; Epi, epirubicin; relativni rizik, kao referenciju uzima se usporedni lijek; omjer rizika, Myocet liposomal kao referentni lijek a sekundarni ishod
English: If you get Myocet liposomal on your skin
Croatian: Ako se Myocet liposomal nađe na Vašoj koži
English: RECOMMENDATIONS FOR SAFE HANDLING
Croatian: PREPORUKE ZA SIGURNO RUKOVANJE
English: These acute phenomena may be avoided by using a 1-hour infusion time.
Croatian: Te akutne pojave mogu se izbjeći primjenom infuzije u trajanju od 1 sata.
English: • Women who could get pregnant should use effective contraception during treatment with Myocet liposomal and for 6 months after treatment.
Croatian: • Žene koje bi mogle zatrudnjeti trebaju koristiti djelotvorne metode sprječavanja začeća tijekom liječenja lijekom Myocet liposomal te još 6 mjeseci nakon liječenja.
English: These methods should also be applied routinely during Myocet liposomal treatment.
Croatian: Te metode treba također rutinski primjenjivati tijekom liječenja lijekom Myocet liposomal.
English: Vial 3 - buffer sodium carbonate, water for injections
Croatian: Bočica 3 - pufer natrijev karbonat, voda za injekcije
English: Transient ECG changes such as T-wave flattening, S-T segment depression and benign arrhythmias are not considered mandatory indications for the cessation of Myocet liposomal therapy.
Croatian: Prolazne promjene u EKG-u poput zaravnjenja T-vala, pada u S-T segmentu i benignih aritmija ne smatraju se obveznim indikacijama za prekid terapije lijekom Myocet liposomal.
English: The cardiac function of the patients treated concomitantly with Myocet liposomal and trastuzumab must be appropriately monitored as described below.
Croatian: Srčanu funkciju bolesnika istodobno liječenih lijekom Myocet liposomal i trastuzumabom mora se nadzirati na odgovarajući način kako je to opisano u nastavku.
English: Safety and efficacy of Myocet liposomal have been assessed in 61 patients with metastatic breast cancer, age 65 and over.
Croatian: Sigurnost i djelotvornost lijeka Myocet liposomal ispitana je na 61 bolesnici s metastatskim karcinomom dojke u dobi od 65 godina i nadalje.
English: - The other ingredients are lactose (in the doxorubicin HCl vial), phosphatidylcholine, cholesterol, citric acid, sodium hydroxide and water for injections (in the liposomes vial), and sodium carbonate and water for injections (in the buffer vial).
Croatian: - Drugi sastojci su laktoza (u bočici s doksorubicin HCl-om), fosfatidilkolin, kolesterol, citratna kiselina, natrijev hidroksid i voda za injekcije (u bočici s liposomima) te natrijev karbonat i voda za injekcije (u bočici s puferom).
English: In addition to these three components, 0.9% (w/v) sodium chloride solution for injection will also be required for the reconstitution of the doxorubicin HCl.
Croatian: Pored ova tri sastojka, bit će potrebna i otopina natrijeva klorida 0,9% (w/v) za injekciju za rekonstituciju doksorubicin HCl-a.
English: The following dosage modifications are recommended during therapy and should be performed in parallel for both Myocet liposomal and cyclophosphamide.
Croatian: Sljedeće izmjene doze preporučuju se tijekom liječenja te ih treba provoditi paralelno s lijekom Myocet liposomal i ciklofosfamidom.
English: This includes medicines obtained without a prescription and herbal medicines.
Croatian: To uključuje i bezreceptne i biljne lijekove.
English: For dose reductions due to other toxicity, see section 4.4.
Croatian: Za smanjenje doze zbog drugih toksičnih učinaka vidjeti dio 4.4.
English: The evaluation of left ventricular function is considered mandatory before each additional administration of Myocet liposomal once a patient exceeds a lifetime cumulative anthracycline dose of 550 mg/m2 or whenever cardiomyopathy is suspected.
Croatian: Procjena funkcije lijeve klijetke smatra se obaveznom prije svake dodatne primjene lijeka Myocet liposomal kad bolesnik premaši doživotnu kumulativnu dozu antraciklina od 550 mg/m2 ili kad god se sumnja na kardiomiopatiju.
English: Note that Myocet liposomal may be administered through a central or peripheral vein.
Croatian: Vodite računa da se Myocet liposomal može primijeniti kroz središnju ili perifernu venu.
English: Bilirubin < ULN and raised AST
Croatian: Bilirubin < GGN i povišeni AST
English: There is no experience with Myocet liposomal in patients with a history of cardiovascular disease, e.g. myocardial infarction within 6 months prior to treatment.
Croatian: Nema iskustva s lijekom Myocet liposomal u bolesnika s anamnezom kardiovaskularne bolesti, primjerice infarkta miokarda unutar 6 mjeseci prije liječenja.
English: Please also read the patient information leaflet carefully that comes with that medicine.
Croatian: Pročitajte također pažljivo Uputu o lijeku koja se isporučuje s lijekom.
English: • stomach pains which may be a sign of a stomach ulcer forming
Croatian: • bolovi u trbuhu koji mogu značiti nastanak čira
English: When infused rapidly acute reactions associated with liposomal infusions have been reported.
Croatian: Prilikom brzog infundiranja primijećene su akutne reakcije povezane s infuzijom liposoma.
English: 1 Painless ulcers, erythema, or mild soreness.
Croatian: 1 Bezbolne ulceracije, eritem ili blaga bolnost.
English: The pharmacokinetics of Myocet liposomal have not been specifically studied in patients with renal insufficiency.
Croatian: Farmakokinetika lijeka Myocet liposomal nije specifično proučavana u bolesnika s bubrežnom insuficijencijom.
English: Studies of the effect of Myocet liposomal on other substances are also lacking.
Croatian: Ispitivanja utjecaja lijeka Myocet liposomal na druge tvari također manjkaju.
English: Findings regarding response rate and progression-free survival are provided in Table 3.
Croatian: Nalazi u vezi stope odgovora i preživljenja bez napretka bolesti nalaze se u tablici 3. Tablica 3
English: • swollen or flushed face
Croatian: • oteklina ili crvenilo lica
English: Myocet liposomal is supplied as a three-vial system as follows:
Croatian: Myocet liposomal se isporučuje kao sustav od tri bočice prema sljedećem:
English: - Do not use this medicine after the expiry date stated on the label and carton.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici i pakiranju.
English: Myocet liposomal should not be administered to individuals with absolute neutrophil counts (ANC) lower than 1,500 cells/µl or platelets less than 100,000/µl prior to the next cycle.
Croatian: Myocet liposomal se ne smije davati bolesnicima s apsolutnim brojem neutrofila (ABN) nižim od 1500 stanica/µl ili trombocita manjim od 100 000/µl prije sljedećeg ciklusa.
English: Myocet liposomal liposomes
Croatian: Myocet liposomal liposomi
English: A dose reduction of Myocet liposomal has been shown to be appropriate in patients with impaired hepatic function (see section 4.2 for dosage recommendations).
Croatian: Smanjenje doze lijeka Myocet liposomal pokazalo se odgovarajućim u bolesnika s oštećenjem jetrene funkcije (vidjeti dio 4.2 za preporuke o doziranju).
English: Myocet liposomal contains a medicine called “doxorubicin”, which damages tumour cells.
Croatian: Myocet liposomal sadrži lijek zvan „doksorubicin“ koji oštećuje tumorske stanice.
English: The total dose of Myocet liposomal should also take into account any previous, or concomitant, therapy with other cardiotoxic compounds, including anthracyclines and anthraquinones.
Croatian: Pri ukupnoj dozi lijekom Myocet liposomal također treba uzeti u obzir svako prethodno ili istodobno liječenje drugim kardiotoksičnim lijekovima uključujući antracikline i antrakinone.
English: SHAKE VIGOROUSLY.
Croatian: SNAŽNO PROTRESITE.
English: Carefully insert a pressure-venting device equipped with a hydrophobic filter.
Croatian: Pažljivo umetnite uređaj za odzračivanje opremljen hidrofobnim filterom.
English: Myocet liposomal is supplied as a three-vial system: (1) doxorubicin HCl, (2) liposomes, and (3) buffer.
Croatian: Myocet liposomal se isporučuje kao sustav od tri bočice: (1) doksorubicin HCl, (2) liposomi i (3) pufer.
English: Vial 2 - liposomes
Croatian: Bočica 2 - liposomi
English: Ice may be applied to the affected area for approximately 30 minutes.
Croatian: Na zahvaćeno područje može se staviti led na približno pola sata.
English: Pressure build-up may require venting.
Croatian: Porast tlaka može zahtijevati odzračivanje.
English: Excipient(s) with known effect: The reconstituted medicinal product contains approximately 108 mg sodium for a 50 mg doxorubicin HCl dose.
Croatian: Pomoćna(e) tvar(i) s poznatim učinkom: Rekonstituirani lijek sadrži približno 108 mg natrija za dozu od 50 mg doksorubicin HCl-a.
English: • Withdraw 20 ml sodium chloride solution for injection (0.9%), (not provided in the package), and inject into each vial of doxorubicin HCl, intended for preparation.
Croatian: • Izvucite 20 ml otopine natrijeva klorida za injekciju (0,9%), (ne isporučuje se u pakiranju) te injicirajte u svaku bočicu doksorubicin HCl, namijenjenu za pripremu.
English: Neutropenic sepsis
Croatian: Često neutropenijska sepsa
English: Talk to your doctor or nurse before having Myocet liposomal.
Croatian: Obratite se svom liječniku ili medicinskoj sestri prije nego primijenite Myocet liposomal.
English: These include flushing, fever, chills, headaches and back pain.
Croatian: To uključuje crvenilo, vrućicu, zimicu, glavobolje i bol u leđima.
English: Bilirubin < ULN and normal AST
Croatian: Bilirubin < GGN i normalan AST
English: Do not use the preparation if foreign particulate matter is present.
Croatian: Otopina se ne smije koristiti ako su u njoj prisutne strane čestice.
English: However, no significant differences were identified in the occurrence of anaemia, thrombocytopenia and episodes of neutropenic fever.
Croatian: No, značajne su razlike identificirane kod pojave anemije, trombocitopenije i epizoda neutropenijske vrućice.
English: • WAIT for a minimum of 10 MINUTES before using, keeping the medicine at room temperature.
Croatian: • Prije primjene PRIČEKAJTE najmanje 10 MINUTA držeći lijek na sobnoj temperaturi.
English: • Remove the reconstituted doxorubicin HCl vial from the water bath or dry heat block.
Croatian: • Izvadite bočicu s rekonstituiranim doksorubicin HCl-om iz vodene kupelji ili suhog bloka za zagrijavanje.
English: In animals, liposome-encapsulated doxorubicin reduced the distribution to heart and gastrointestinal mucosa compared with conventional doxorubicin, while antitumoural efficacy in experimental tumours was maintained.
Croatian: Kod životinja, liposomom enkapsulirani doksorubicin smanjio je raspodjelu lijeka u srce i gastrointestinalnu sluznicu u usporedbi sa standardnim doksorubicinom dok je antitumorska djelotvornost u eksperimentalnim tumorima bila održana.
English: Studies of genotoxicity, carcinogenicity and reproductive toxicity of Myocet liposomal have not been performed but doxorubicin is known to be both mutagenic and carcinogenic and may cause toxicity to reproduction.
Croatian: 5.3 Neklinički podaci o sigurnosti primjene Ispitivanja genotoksičnosti, karcinogenosti i reproduktivne toksičnosti lijeka Myocet liposomal nisu provedena, ali je poznato da doksorubicin ima i mutagena i kancerogena svojstva te može uzrokovati reproduktivnu toksičnost.
English: During clinical trials, the most frequently reported adverse reactions were nausea/vomiting (73%), leucopoenia (70%), alopecia (66%), neutropenia (46%), asthenia/fatigue (46%), stomatitis/mucositis (42%), thrombocytopenia (31%) and anaemia (30%).
Croatian: leukopenija (70%), alopecija (66%), neutropenija (46%), astenija/umor (46%), stomatitis/mukozitis (42%), trombocitopenija (31%) i anemija (30%).
English: The clearance of total doxorubicin was 5.1 ± 4.8 l/h and the volume of distribution at steady state (Vd) was 56.6 ± 61.5 l whereas after conventional doxorubicin, clearance and Vd were 46.7 ± 9.6 l/h and 1,451 ± 258 l, respectively.
Croatian: Klirens doksorubicina iznosio je 5,1 ± 4,8 l/h i volumen raspodjele u stanju dinamičke ravnoteže (Vd) iznosio je 56,6 ± 61,5 l dok su klirens i Vd nakon primjene standardnog doksorubicina iznosili 46,7 ± 9,6 l/h odnosno 1,451 ± 258 l.
English: Dosing subsequent to a dose reduction is left to the discretion of the physician in charge of the patient.
Croatian: Doziranje nakon smanjenja doze odluka je bolesnikova liječnika.
English: Two alternative heating methods can be used : a Techne DB-3 Dri Block heater or a water bath:
Croatian: Mogu se koristiti dvije metode zagrijavanja: grijač Techne DB-3 Dri Block ili vodena kupelj:
English: Myocet liposomal, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in adult women.
Croatian: Myocet liposomal, u kombinaciji s ciklofosfamidom, indiciran je kao prva linija liječenja metastatskog karcinoma dojke u odraslih žena.
English: Myocet liposomal should be considered an irritant and precautions should be taken to avoid extravasation.
Croatian: Myocet liposomal treba smatrati nadražujućim te je potrebno poduzeti odgovarajuće mjere kako bi se izbjegla ekstravazacija.
English: Acute overdose with Myocet liposomal will worsen toxic side effects.
Croatian: Akutno predoziranje lijekom Myocet liposomal može pogoršati toksične nuspojave.
English: Reported symptoms have included flushing, dyspnoea, fever, facial swelling, headache, back pain, chills, tightness in the chest and throat, and/or hypotension.
Croatian: Prijavljeni simptomi uključivali su crvenilo uz osjećaj užarenosti, dispneju, vrućicu, oticanje lica, glavobolju, bol u leđima, zimicu, stezanje u prsima i grlu i/ili hipotenziju.
English: The safety and efficacy of Myocet liposomal in children aged up to 17 years has not been established.
Croatian: Djelotvornost i sigurnost lijeka Myocet liposomal u djece u dobi do 17 godina ustanovljena.
English: • feeling agitated, feeling sleepy
Croatian: • osjećaj uzrujanosti, pospanost
English: Vial 2 - liposomes phosphatidylcholine, cholesterol, citric acid, sodium hydroxide, water for injections
Croatian: Bočica 2 - liposomi fosfatidilkolin, kolesterol, citratna kiselina, natrijev hidroksid, voda za injekcije
English: Verify the temperature set point by checking the thermometer(s) on each heat block insert.
Croatian: Postavljenu temperaturnu točku provjerite na termometru na svakom umetku bloka grijača.
English: This corresponds to 50 mg doxorubicin hydrochloride.
Croatian: To odgovara 50 mg doksorubicinklorida.
English: It has been demonstrated that once reconstituted Myocet liposomal has a chemical and physical in-use stability at room temperature for up to 8 hours or in a refrigerator (2
Croatian: Dokazano je da je rekonstituirani Myocet liposomal u primjeni kemijski i fizikalno stabilan do 8 sati pri sobnoj temperaturi ili do 5 dana u hladnjaku (2°C - 8°C).
English: The corresponding figures for congestive heart failure, which was less accurately assessed, were 0% for Myocet liposomal + CPA versus 3% for doxorubicin + CPA, and 2% for Myocet liposomal versus 8% for doxorubicin.
Croatian: Odgovarajuće brojke za kongestivno zatajenje srca, koje je bilo manje točno procijenjeno, iznosile su 0% za Myocet liposomal + CPA naspram 3% za doksorubicin + CPA te 2% za Myocet liposomal naspram 8% za doksorubicin.
English: In general however, the plasma levels of total doxorubicin are substantially higher with Myocet liposomal than with conventional doxorubicin, while the data indicate that peak plasma levels of free (not liposome-encapsulated) doxorubicin are lower with Myocet liposomal than with conventional doxorubicin.
Croatian: Međutim, uglavnom su koncentracije doksorubicina u plazmi znatno više s lijekom Myocet liposomal nego sa standardnim doksorubicinom dok podaci ukazuju da su vršne plazmatske vrijednosti slobodnog (nekapsuliranog u liposomima) doksorubicina niže s lijekom Myocet liposomal nego sa standardnom doksorubicinom.
English: Myocet liposomal is used in adult women for the first-line treatment of breast cancer that has spread (“metastatic breast cancer”).
Croatian: Myocet liposomal se koristi u odraslih žena kao lijek prvog izbora za karcinom dojke koji se raširio po tijelu („metastatski karcinom dojke“).
English: The use of Myocet liposomal should be confined to units specialised in the administration of cytotoxic chemotherapy and should only be administered under the supervision of a physician experienced in the use of chemotherapy.
Croatian: Primjenu lijeka Myocet liposomal treba ograničiti na odjele koji su specijalizirani u primjeni citotoksičnih lijekova te ih treba primjenjivati samo pod nadzorom liječnika iskusnog u primjeni kemoterapije.
English: The following adverse reactions have been reported with Myocet liposomal during clinical studies and post marketing experience.
Croatian: Sljedeće su nuspojave prijavljene s lijekom Myocet liposomal tijekom kliničkih ispitivanja te nakon stavljanja lijeka u promet.
English: As metabolism and excretion of doxorubicin occurs primarily by the hepatobiliary route, evaluation of hepatobiliary function should be performed before and during therapy with Myocet liposomal.
Croatian: Metabolizam i izlučivanje doksorubicina događa se primarno putem jetre i žuči pa je stoga potrebno procijeniti funkciju jetre i žuči prije i tijekom liječenja lijekom Myocet liposomal.
English: Therefore dose modification is not required for patients with renal function impairment.
Croatian: Stoga izmjena doze nije potrebna u bolesnika s oštećenjem bubrega.
English: If any of the above apply to you (or you are not sure), please talk to your doctor or nurse before having Myocet liposomal.
Croatian: Ako se išta od gore navedenog odnosi na Vas (ili ako niste sigurni), molimo razgovarajte sa svojim liječnikom ili medicinskom sestrom prije početka uzimanja lijeka Myocet liposomal.
English: • if you are allergic to doxorubicin or any of the other ingredients of this medicine (listed in section Do not have Myocet liposomal if this applies to you.
Croatian: • ako ste alergični na doksorubicin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).
English: • sodium carbonate
Croatian: • natrijev karbonat
English: Specific medicinal product compatibility studies have not been performed with Myocet liposomal.
Croatian: Specifična ispitivanja kompatibilnosti lijekova s lijekom Myocet liposomal nisu provedena.
English: • If using a water bath, turn on the water bath and allow it to equilibrate at 58°C (55°C-60°C).
Croatian: • Ako koristite vodenu kupelj, uključite je i omogućite postizanje toplinske ravnoteže na 58°C (55°C- 60°C).
English: • fever, chills, pain
Croatian: • vrućica, zimica, bol
English: When Myocet liposomal is administered in combination with cyclophosphamide (600 mg/m2) the initial recommended dose of Myocet liposomal is 60-75 mg/m2 every three weeks.
Croatian: Kad se Myocet liposomal primjenjuje u kombinaciji s ciklofosfamidom (600 mg/m2) početna preporučena doza lijeka Myocet liposomal iznosi 60-75 mg/m2 svaka tri tjedna.
English: However, the most definitive test for anthracycline myocardial injury, i.e., endomyocardial biopsy, should be considered.
Croatian: Međutim, kao konačnu potvrdu ozljede miokarda uzrokovane antraciklinima treba uzeti u obzir biopsiju endomiokarda.
English: Common (may affect up to 1 in 10 people):
Croatian: Često (mogu pogoditi najviše 1 od 10 osoba):
English: • citric acid
Croatian: • citratna kiselina
English: Myocet liposomal is administered by intravenous infusion over a period of 1 hour.
Croatian: Myocet liposomal se primjenjuje intravenskom infuzijom u trajanju od 1 sata.
English: 2 Painful erythema, oedema or ulcers but can eat.
Croatian: 2 Bolni eritem, edem ili ulceracije ali bolesnik može jesti.
English: The median lifetime cumulative dose of Myocet liposomal in combination with CPA to a cardiac event was > 1260 mg/m2, compared to 480 mg/m2 for doxorubicin combination with CPA.
Croatian: Medijan doživotne kumulativne doze lijeka Myocet liposomal u kombinaciji s CPA za srčani događaj iznosio je > 1260 mg/m2 u usporedbi s 480 mg/m2 za doksorubicin u kombinaciji s CPA.
English: Blood and lymphatic system disorders
Croatian: Poremećaji krvi i limfnog sustava neutropenija
English: Efficacy and safety of Myocet liposomal in the adjuvant treatment of breast cancer have not been determined.
Croatian: Djelotvornost i sigurnost lijeka Myocet liposomal u pomoćnom liječenju karcinoma dojke nije utvrđena.
English: Myocet liposomal is available in cartons containing 1 set or 2 sets of 3 vials (not all pack-sizes may be marketed).
Croatian: Myocet liposomal je dostupan u kutijama koje sadrže 1 ili 2 kompleta s 3 bočice (na tržištu se ne moraju nalaziti sve veličine pakiranja).
English: Dox (75 mg/m2) (n=116)
Croatian: Doks (75 mg/m2) (n=116)
English: Before initiation of Myocet liposomal therapy a measurement of left ventricular ejection fraction (LVEF) is routinely recommended, either by Multiple Gated Arteriography (MUGA) or by echocardiography.
Croatian: Prije početka liječenja lijekom Myocet liposomal rutinski se preporučuje mjerenje istisne frakcije lijeve klijetke (LVEF) bilo putem radionuklidne arteriografije (MUGA) ili ehokardiografije.
English: Dox 60/CPA mg/m2) (n=155)
Croatian: Doks 60/CPA mg/m2) (n=155)
English: • Turn on the Techne DB-3 Dri Block heater and set the controller to 75°C-76°C.
Croatian: • Uključite grijač Techne DB-3 Dri Block i postavite kontrolni uređaj na temperaturu od 75°C
English: Other medicines and Myocet liposomal
Croatian: Drugi lijekovi i Myocet liposomal
English: Subsequently, the Myocet liposomal infusion should be restarted in a different vein than that in which the extravasation has occurred.
Croatian: Kasnije se infuzija lijeka Myocet liposomal može ponovno pokrenuti, ali ne u veni na kojoj se dogodila ekstravazacija.
English: Weight loss
Croatian: Često gubitak težine
English: Heat in water bath or dry heat block
Croatian: 3. korak Zagrijte u vodenoj kupelji ili na bloku za grijanje
English: Breast-feeding Women receiving Myocet liposomal should not breastfeed.
Croatian: Dojenje Žene koje uzimaju Myocet liposomal ne smiju dojiti.
English: A final concentration of between 0.4 mg/ml to 1.2 mg/ml doxorubicin HCl, is required.
Croatian: Potrebna je konačna koncentracija lijeka između 0,4 i 1,2 mg/ml doksorubicina hidroklorida.
English: Consider a 25% dose reduction
Croatian: Razmotriti smanjenje doze za 25%
English: Warning: Myocet liposomal must not be administered by the intramuscular or subcutaneous route or as a bolus injection.
Croatian: Upozorenje: Myocet liposomal se ne smije primjenjivati intramuskularno ili supkutano ili u obliku bolus injekcije.
English: The normal procedures for proper handling and disposal of anti-tumour medicinal products should be adopted, namely:
Croatian: Potrebno je usvojiti uobičajene postupke za ispravno rukovanje i odlaganje antitumorskih lijekova, a posebice: • Djelatnike treba obučiti rekonstituciji lijeka.
English: The importance of apparent differences in tissue distribution between Myocet liposomal and conventional doxorubicin has not been elucidated with respect to long-term antitumour efficacy.
Croatian: Važnost očite razlike u raspodjeli po tkivima između lijeka Myocet liposomal i standardnog doksorubicina s obzirom na dugoročnu antitumorsku djelotovornost nije dokazana.
English: This is based on the size of your body (measured in “square metres” or “m2”).
Croatian: To se temelji na veličini Vašeg tijela (mjereno u
English: OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUHTORISATION
Croatian: OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET
English: • Women having Myocet liposomal should not breast-feed.
Croatian: • Žene koje uzimaju Myocet liposomal ne smiju dojiti.